image
Healthcare - Medical - Devices - NASDAQ - US
$ 5.595
5.06 %
$ 352 M
Market Cap
-6.6
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Aug, 5, 2025.

The intrinsic value of one TMCI stock under the worst case scenario is HIDDEN Compared to the current market price of 5.59 USD, Treace Medical Concepts, Inc. is HIDDEN

This DCF valuation model was last updated on Aug, 5, 2025.

The intrinsic value of one TMCI stock under the base case scenario is HIDDEN Compared to the current market price of 5.59 USD, Treace Medical Concepts, Inc. is HIDDEN

This DCF valuation model was last updated on Aug, 5, 2025.

The intrinsic value of one TMCI stock under the best case scenario is HIDDEN Compared to the current market price of 5.59 USD, Treace Medical Concepts, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart TMCI

image
$10.5$10.5$10.0$10.0$9.5$9.5$9.0$9.0$8.5$8.5$8.0$8.0$7.5$7.5$7.0$7.0$6.5$6.5$6.0$6.0$5.5$5.5$5.0$5.015 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '2515 Jun15 JunJul '25Jul '2515 Jul15 JulAug '25Aug '25
FINANCIALS
209 M REVENUE
11.89%
-55.7 M OPERATING INCOME
-8.28%
-55.7 M NET INCOME
-12.55%
-37.2 M OPERATING CASH FLOW
-7.50%
35.4 M INVESTING CASH FLOW
143.51%
160 K FINANCING CASH FLOW
-99.85%
52.6 M REVENUE
-23.49%
-15.6 M OPERATING INCOME
-7538.24%
-15.9 M NET INCOME
-3078.04%
4.2 M OPERATING CASH FLOW
199.79%
-1.89 M INVESTING CASH FLOW
-55.36%
-282 K FINANCING CASH FLOW
-1084.62%
Balance Sheet Treace Medical Concepts, Inc.
image
Current Assets 161 M
Cash & Short-Term Investments 75.7 M
Receivables 40.8 M
Other Current Assets 44.9 M
Non-Current Assets 55.7 M
Long-Term Investments 0
PP&E 34.4 M
Other Non-Current Assets 21.3 M
34.86 %18.80 %20.69 %15.84 %9.81 %Total Assets$217.1m
Current Liabilities 34.9 M
Accounts Payable 10.5 M
Short-Term Debt 413 K
Other Current Liabilities 24 M
Non-Current Liabilities 69.3 M
Long-Term Debt 69.2 M
Other Non-Current Liabilities 37 K
10.10 %23.02 %66.45 %Total Liabilities$104.2m
EFFICIENCY
Earnings Waterfall Treace Medical Concepts, Inc.
image
Revenue 209 M
Cost Of Revenue 41.1 M
Gross Profit 168 M
Operating Expenses 224 M
Operating Income -55.7 M
Other Expenses 55 K
Net Income -55.7 M
250m250m200m200m150m150m100m100m50m50m00(50m)(50m)(100m)(100m)209m(41m)168m(224m)(56m)(55k)(56m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
80.37% GROSS MARGIN
80.37%
-26.60% OPERATING MARGIN
-26.60%
-26.63% NET MARGIN
-26.63%
-49.38% ROE
-49.38%
-25.68% ROA
-25.68%
-30.50% ROIC
-30.50%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Treace Medical Concepts, Inc.
image
00(5m)(5m)(10m)(10m)(15m)(15m)(20m)(20m)(25m)(25m)(30m)(30m)(35m)(35m)(40m)(40m)(45m)(45m)(50m)(50m)202020202021202120222022202320232024202420252025
Net Income -55.7 M
Depreciation & Amortization 8.42 M
Capital Expenditures -11.6 M
Stock-Based Compensation 0
Change in Working Capital -25.4 M
Others 1.73 M
Free Cash Flow -48.8 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Treace Medical Concepts, Inc.
image
Wall Street analysts predict an average 1-year price target for TMCI of $13.3 , with forecasts ranging from a low of $9.5 to a high of $16 .
TMCI Lowest Price Target Wall Street Target
9.5 USD 69.79%
TMCI Average Price Target Wall Street Target
13.3 USD 138.31%
TMCI Highest Price Target Wall Street Target
16 USD 185.97%
Price
Max Price Target
Min Price Target
Average Price Target
1616141412121010886644Sep '24Sep '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 7
6. Ownership
Insider Ownership Treace Medical Concepts, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
398 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
524 K USD 1
3-6 MONTHS
0 USD 0
6-9 MONTHS
1.28 M USD 2
9-12 MONTHS
7. News
Kuehn Law Encourages Investors of Treace Medical Concepts, Inc. to Contact Law Firm NEW YORK , June 11, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Treace Medical Concepts, Inc. (NASDAQ: TMCI)  breached their fiduciary duties to shareholders.  According to a federal securities lawsuit, Insiders at Treace Medical caused the company to misrepresent or fail to disclose (1) competition impacted the demand for and utilization of its primary product, the Lapiplasty 3D Bunion Correction System; (2) as a result, Treace Medical's revenue declined, and the Company needed to accelerate its plans to offer a product that served as an alternative to osteotomy (a surgical procedure involving the cutting and realignment of a bone to improve its position or function); and (3) positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. prnewswire.com - 1 month ago
Securities Lawsuit Alert: Treace Medical Concepts, Inc. (TMCI) Investors - Contact Levi & Korsinsky Before June 10, 2025 NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=152492&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq. accessnewswire.com - 1 month ago
Securities Class Action Lawsuit Filed Against Treace Medical Concepts, Inc. (TMCI) - Levi & Korsinsky Represents Shareholders NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=152481&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq. accessnewswire.com - 1 month ago
TMCI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Treace Medical Concepts, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Treace Medical Concepts, Inc. (“Treace Medical” or “the Company”) (NASDAQ: TMCI) and certain of its officers. globenewswire.com - 1 month ago
Lost Money on Treace Medical Concepts, Inc. (TMCI)? Join Class Action Before June 10, 2025 - Contact Levi & Korsinsky NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=152456&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq. accessnewswire.com - 1 month ago
Class Action Filed Against Treace Medical Concepts, Inc. (TMCI) - June 10, 2025 Deadline to Join – Contact Levi & Korsinsky NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Treace Medical Concepts, Inc. ("Treace Medical Concepts, Inc." or the "Company") (NASDAQ: TMCI) of a class action securities lawsuit. globenewswire.com - 1 month ago
Securities Fraud Class Action Filed Against Treace Medical Concepts, Inc. (TMCI) - Levi & Korsinsky Reminds Investors of June 10, 2025 NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=152443&wire=1&utm_campaign=27 or contact Joseph E. Levi, Esq. accessnewswire.com - 1 month ago
TMCI DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important June 10 Deadline in Securities Class Action - TMCI NEW YORK, NY / ACCESS Newswire / June 10, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Treace Medical Concepts, Inc. (NASDAQ:TMCI) between May 8, 2023 and May 7, 2024, both dates inclusive (the "Class Period"), of the important June 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Treace Medical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. accessnewswire.com - 1 month ago
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical NEW YORK--(BUSINESS WIRE)---- $TMCI #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NASDAQ: TMCI) and reminds investors of the June 10, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. businesswire.com - 1 month ago
Did You Lose Money on Treace Medical Concepts, Inc. (TMCI)? Levi & Korsinsky Urges Investors to Act Before June 10, 2025 NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=152392&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq. accessnewswire.com - 1 month ago
8. Profile Summary

Treace Medical Concepts, Inc. TMCI

image
COUNTRY US
INDUSTRY Medical - Devices
MARKET CAP $ 352 M
Dividend Yield 0.00%
Description Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.
Contact 203 Fort Wade Road, Ponte Vedra, FL, 32081 https://www.treace.com
IPO Date April 23, 2021
Employees 477
Officers Dr. Sean F. Scanlan Ph.D. Chief Innovation Officer Mr. Aaron J. Berutti Senior Vice President of Sales Mr. Taylor Erickson Chief Information & Cybersecurity Officer Mr. Daniel E. Owens Chief Human Resources Officer Mr. Scot M. Elder J.D. Chief Legal & Compliance Officer and Corporate Secretary Mr. Terry W. Lubben Chief Operations & Supply Chain Officer Ms. Shana Zink Senior Vice President of Clinical Affairs & Reimbursement Mr. John T. Treace Chief Executive Officer, Founder & Director Mr. Gaetano M. Guglielmino Chief Commercial Officer Mr. Mark L. Hair CPA Chief Financial Officer